| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 48.10M | — |
| Operating expense | — | — |
| Net income | -260.54M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HNSA.ST returned +26.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +21.8% |
| 1 year | +26.8% |
| 5 years | -66.3% |
| 10 years | -43.8% |
| All-time high | kr 336.60 (Sep 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in HNSA.ST would be worth today ›No. Hansa Biopharma AB (publ) has not paid a dividend in the past 12 months.
Hansa Biopharma AB (publ) is part of the Healthcare sector.
Hansa Biopharma AB (publ) has a market cap of 4.17B SEK, based on the latest quote.
